Riskpilot← Back to searchSign inGet full accessAB HemCura
ABActiveOrg 5592349871Osby Tappavittsvägen 22Mixed farming · NACE 0150Est. 20200 employees
Revenue 2024
SEK 1,4M
+675% vs 2023
EBITDA margin
7.3%
+24% vs 2023
Equity ratio
55.6%
Financial strength
Net profit 2024
SEK 78K
+24% vs 2023
| Revenue | SEK 1,4M | +675% |
| EBITDA | SEK 103K | +24% |
| Net profit | SEK 78K | +24% |
| Total assets | SEK 293K | +30% |
| Equity | SEK 163K | +86% |
| Employees | 0 | — |
Legal name
AB HemCura
Org number
5592349871
Legal form
Aktiebolag
NACE code
0150 · Mixed farming
Founded
2 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hemtjänstverksamhet, vård- och omsorgsboende samt därmed förenlig verksamhet.
Address
Osby Tappavittsvägen 22
Email
hemcura@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 181 | 1 405 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | — | 83 | 103 |
| Depreciation & amort. | −0 | −0 | — | −4 | −5 |
| EBIT | 0 | 0 | 0 | 79 | 98 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 79 | 98 |
| Tax | −0 | −0 | — | −16 | −20 |
| Net profit | 0 | 0 | — | 63 | 78 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 | 25 | 25 | 225 | 293 |
| Equity | 25 | 25 | 25 | 88 | 163 |
| Long-term debt | 0 | 0 | — | 22 | 0 |
| Short-term debt | 0 | 0 | — | 115 | 130 |
| Total debt | — | — | — | 137 | 130 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20202024
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
47.9%
This company
18.4%
Market median
+160% vs market
20202024
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20202024
Asset turnover
4.80×
This company
1.12×
Market median
+329% vs market
20202024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Deputy Board Member | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB HemCura also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sarmad Khudhair Abbas | Chief Executive Officer | 0 companies |
| Mohammed Al-Rijab | Chairman | 0 companies |
| Majid Khudhair Abbas Algalali | Deputy Board Member | 0 companies |
| Refel Karim | Chairman | 0 companies |
| Walid Alsaffar | Deputy Board Member | 0 companies |